These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22913327)
21. Bone scintigraphy for early detection of transthyretin cardiac amyloidosis. Ikram A J Pak Med Assoc; 2016 Aug; 66(8):1045. PubMed ID: 27524550 [No Abstract] [Full Text] [Related]
22. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207 [TBL] [Abstract][Full Text] [Related]
23. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis. Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369 [TBL] [Abstract][Full Text] [Related]
24. Estimating cancer risk from Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972 [TBL] [Abstract][Full Text] [Related]
25. A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting. Shetty M J Nucl Cardiol; 2021 Apr; 28(2):604-609. PubMed ID: 33655447 [No Abstract] [Full Text] [Related]
26. Imaging in systemic amyloidosis. Sachchithanantham S; Wechalekar AD Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486 [TBL] [Abstract][Full Text] [Related]
28. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up? Ruberg FL; Miller EJ Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778 [No Abstract] [Full Text] [Related]
29. Radionuclide Imaging of Cardiac Amyloidosis. Joseph V; Julien HM; Bravo PE PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384 [TBL] [Abstract][Full Text] [Related]
30. A potential pitfall in the use of Murray CSG; Moadel RM; Tauras JM; Zamora E; Travin MI J Nucl Cardiol; 2021 Oct; 28(5):2395-2398. PubMed ID: 32449000 [No Abstract] [Full Text] [Related]
31. Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis? Algalarrondo V; Piekarski E; Eliahou L; Le Guludec D; Slama MS; Rouzet F Curr Cardiol Rep; 2018 Mar; 20(5):33. PubMed ID: 29574587 [TBL] [Abstract][Full Text] [Related]
32. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy]. Sekijima Y Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679 [TBL] [Abstract][Full Text] [Related]